Insulin signaling effects on memory and mood

Current Opinion in Pharmacology

Volumn 7, Issue 6, 2007, Pages 633-637

  Reagan, Lawrence P ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR;

ALZHEIMER DISEASE; BRAIN ATROPHY; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DIABETOGENESIS; DISEASE COURSE; EPIDEMIC; HIPPOCAMPUS; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MEMORY DISORDER; MOOD DISORDER; NERVE CELL PLASTICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SOCIOECONOMICS; VULNERABLE POPULATION;

AFFECT; AGING; ANIMALS; BRAIN; DIABETES MELLITUS; HUMANS; INSULIN; MEMORY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 36549017535     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2007.10.012     Document Type: Review

References (52)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555. The National Health and Nutrition Examination Survey (NHANES) revealed that increasing numbers of children and adolescents may be categorized as overweight. Additionally, greater than 60% of the adult US population may be defined as either overweight or obese.
2. Kamal A., Biessels G.-J., Duis S.E.J., and Gispen W.H. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 43 (2000) 500-506
3. Magariños A.M., and McEwen B.S. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc Natl Acad Sci USA 97 (2000) 11056-11061
4. Grillo C.A., Piroli G.G., Wood G.E., Reznikov L.R., McEwen B.S., and Reagan L.P. Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 136 (2005) 477-486
5. Kim H.B., Jang M.H., Shin M.C., Lim B.V., Kim Y.P., Kim K.J., Kim E.H., and Kim C.J. Treadmill exercise increases cell proliferation in dentate gyrus of rats with streptozotocin-induced diabetes. J Diabetes Complications 17 (2003) 29-33
6. Beauquis J., Roig P., Homo-Delarche F., De Nicola A., and Saravia F. Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment. Eur J Neurosci 23 (2006) 1539-1546
7. Saravia F.E., Beauquis J., Revsin Y., Homo-Delarche F., de Kloet E.R., and De Nicola A.F. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell Mol Neurobiol 26 (2006) 943-957
8. Li Z.G., Zhang W., Grunberger G., and Sima A.A. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 946 (2002) 221-231
9. Magariños A.M., Jain K., Blount E.D., Reagan L., Smith B.H., and McEwen B.S. Peritoneal implantation of microencapsulated porcine pancreatic islets in diabetic rats ameliorates severe hyperglycemia and prevents retraction and simplification of hippocampal dendrites. Brain Res 902 (2001) 282-287
10. Biessels G.-J., Kamal A., Urban I.J., Spruijt B.M., Erkelens D.W., and Gispen W.H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 800 (1998) 125-135
11. Marks J.L., Porte Jr. D., Stahl W.L., and Baskin D.G. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 127 (1991) 3234-3236
12. 125I]Insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats. Neuroscience 80 (1997) 1033-1040
13. Park C.R. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25 (2001) 311-323
14. Kopf S.R., and Baratti C.M. Memory-improving actions of glucose: involvement of a central cholinergic muscarinic mechanism. Behav Neur Biol 62 (1994) 237-243
15. Parkes M., and White K.G. Glucose attenuation of memory impairments. Behav Neurosci 114 (2000) 307-319
16. Park C.R., Seely R.J., Craft S., and Woods S.C. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 68 (2000) 509-514
17. Winocur G., and Gagnon S. Glucose treatment attenuates spatial learning and memory deficts of aged rats on tests of hippocampal function. Neurobiol Aging 19 (1998) 233-241
18. Messier C., Gagnon M., and Knott V. Effect of glucose and peripheral glucose regulation on memory in the elderly. Neurobiol Aging 18 (1997) 297-304
19. Manning C.A., Stone W.S., Korol D.L., and Gold P.E. Glucose enhancement of 24-h memory retrieval in healthy elderly humans. Behav Brain Res 93 (1998) 71-76
20. Messier C., and Gagnon M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav Brain Res 75 (1996) 1-11
21. Manning C.A., Ragozzino M.E., and Gold P.E. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol Aging 14 (1993) 523-528
22. Craft S., Asthana S., Newcomer J.W., Wilkinson C.W., Matos I.T., Baker L.D., Cherrier M., Lofgreen C., and Latendresse S. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 56 (1999) 1135-1140
23. Greenwood C.E., and Winocur G. Glucose treatment reduces memory deficits in young adult rats fed high-fed diets. Neurobiol Learn Mem 75 (2001) 179-189
24. Zhao W., Chen H., Moore E., Meiri N., Quon M.J., and Alkon D.L. Brain insulin receptors and spatial memory. J Biol Chem 274 (1999) 34893-34902
25. McEwen B.S., and Reagan L.P. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 490 (2004) 13-24
26. Choeiri C., Hewitt K., Durkin J., Simard C.J., Renaud J.M., and Messier C. Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice. Behav Brain Res 157 (2005) 31-38
27. Dou J.T., Chen M., Dufour F., Alkon D.L., and Zhao W.Q. Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem 12 (2005) 646-655. Streptozotocin (STZ) diabetic rats display some subtle performance deficits compared with control rats, which may explain the discrepancies in studies that have examined water maze performance in STZ rats. Behavioral training elicited increases in insulin receptor signaling in the hippocampus of STZ rats, suggesting that diabetes-induced deficits in insulin signaling represent plastic, not irreversible, changes.
28. Li X.L., Aou S., Oomura Y., Hori N., Fukunaga K., and Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 113 (2002) 607-615
29. Belanger A., Lavoie N., Trudeau F., Massicotte G., and Gagnon S. Preserved LTP and water maze learning in hyperglycaemic-hyperinsulinemic ZDF rats. Physiol Behav 83 (2004) 483-494
30. Winocur G., Greenwood C.E., Piroli G.G., Grillo C.A., Reznikov L.R., Reagan L.P., and McEwen B.S. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci 119 (2005) 1389-1395. Type 2 Zucker diabetic rats performed more poorly in the variable interval delayed alternation task when compared with their lean littermates; these behavioral deficits were associated with impaired insulin receptor signaling. These results strengthen the relationship between insulin signaling and memory and emphasize the importance of test selection when evaluating behavioral performance in diabetic rodents.
31. Reagan L.P. Glucose, stress and hippocampal neuronal vulnerability. Int Rev Neurobiol 51 (2002) 289-324
32. Lobnig B.M., Kromeke O., Optenhostert-Porst C., and Wolf O.T. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications. Diabet Med 23 (2006) 32-39
33. Ferguson S.C., Blane A., Perros P., McCrimmon R.J., Best J.J., Wardlaw J., Deary I.J., and Frier B.M. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52 (2003) 149-156
34. Musen G., Lyoo I.K., Sparks C.R., Weinger K., Hwang J., Ryan C.M., Jimerson D.C., Hennen J., Renshaw P.F., and Jacobson A.M. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55 (2006) 326-333
35. Manschot S.M., Brands A.M., van der G.J., Kessels R.P., Algra A., Kappelle L.J., and Biessels G.J. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55 (2006) 1106-1113
36. den Heijer T., Vermeer S.E., van Dijk E.J., Prins N.D., Koudstaal P.J., Hofman A., and Breteler M.M. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46 (2003) 1604-1610
37. Gold S.M., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., Tsui W., Richardson S., Javier E., and Convit A. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50 (2007) 711-719. Voxel-based morphometric analyses identified decreases in hippocampal formation volume in type 2 diabetes patients; this patient population also exhibited deficits in hippocampal-based declarative memory. Since volumetric changes were restricted to the hippocampus, these results support that hypothesis that the hippocampus is particularly vulnerable to the effects of hyperglycemia and insulin resistance in diabetes/obesity phenotypes.
38. Ryan C.M. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes 7 (2006) 289-297
39. Ryan C.M. Memory and metabolic control in children. Diabetes Care 22 (1999) 1239-1241
40. Leedom L.J., Meehan W.P., and Zeidler A. Avoidance responding in mice with diabetes mellitus. Physiol Behav 40 (1987) 447-451
41. Scribner K.A., Walker C.D., Cascio C.S., and Dallman M.F. Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 129 (1991) 99-108
42. Oster M.H., Castonguay T.M., Keen C.L., and Stern J.S. Circadian rhythm of corticosterone in diabetic rats. Life Sci 43 (1988) 1643-1645
43. Bruehl H., Rueger M., Dziobek I., Sweat V., Tirsi A., Javier E., Arentoft A., Wolf O.T., and Convit A. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab 92 (2007) 2439-2445. Type 2 patients exhibit increased basal levels of cortisol, as well as increased cortisol levels following dexamethasone and CRF administration, indicative of HPA axis hyper-reactivity in this patient population. Additionally, neuroendocrine dysfunction was correlated with declarative memory performance in type 2 patients.
44. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., and Breteler M.M. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53 (1999) 1937-1942
45. Brown E.S., Varghese F.P., and McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biol Psychiatry 55 (2004) 1-9
46. McEwen B.S., Magarinos A.M., and Reagan L.P. Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes. J Psychosom Res 53 (2002) 883-890
47. Lustman P.J., and Clouse R.E. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19 (2005) 113-122. Epidemiological studies suggest that diabetes patients are more than twofold more likely to develop depressive illness when compared with the general population. Diabetic patients with this co-morbidity may experience more severe symptomotology, including increased risk of relapse. The degree of metabolic control maintained by diabetes patients appears to be an important contributor to the development of this co-morbidity.
48. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27 (2006) 24-31. Emerging evidence suggests an important link between increased productions of inflammatory mediators such as pro-inflammatory cytokines and neurochemical/neurotrophic changes in the brain. As such, cytokines and their interactions with stress hormones may participate in the etiology and/or progression of depressive illness.
49. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 4 (2007) 147-152
50. Merani S., and Shapiro A.M. Current status of pancreatic islet transplantation. Clin Sci (Lond) 110 (2006) 611-625. The success of the Edmonton protocol established renewed enthusiasm for pancreatic islet transplantation for the treatment of type 1 diabetes. Emerging technologies for islet survival and islet donors, including porcine islets, as well as advances in immunosuppression strategies, may permit many type 1 patients achieve insulin independence.
51. Air E.L., Strowski M.Z., Benoit S.C., Conarello S.L., Salituro G.M., Guan X.M., Liu K., Woods S.C., and Zhang B.B. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat Med 8 (2002) 179-183
52. Cohen A., and Horton E.S. Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control. Curr Med Res Opin 23 (2007) 905-917